Alkis Papachristos, PharmD, PhD

Postdoctoral Fellow in Clinical Pharmacology and Pharmacogenomics at University of Chicago • Tweets are my own

[Alkis Papachristos, PharmD, PhD @alkis_p]

@drlauraramsey @ChildrensMercy @CincyClinPharm Congratulations

[UChicagoCancerCenter @UCCancerCenter]

📢 @ACSCAN #Pharmacogenomics summit is happening tomorrow!
Join Peter O’Donnell, MD from @UChicagoMed, to learn about University of Chicago’s experiences with prospective PGx testing in it's cancer patient populations. @UCCancerCenter @UChicagoHemOnc
https://t.co/aotnDaFOPp

[Alkis Papachristos, PharmD, PhD @alkis_p]

#ASCO23 day 2 kicks off! Looking forward to the Developmental Therapeutics poster session - Immunotherapy & Molecularly Targeted agents #Immunotherapy #Immunooncoloy #TargetedTreatments🧬@ASCO #CancerResearch

[Raakhee Shah @raakhee_shah]

Pls RT! Let’s help @bekkiburgoyne to reach her goal @Anish_m_tailor @PinkieChambers @meerad30 @ClareGeoghegan @SebMasento @Jharchowal @PaddaAmandeep @DrDereckG @panisphik @BOPACommittee

[Alkis Papachristos, PharmD, PhD @alkis_p]

@BeumerCancer @charleskunos @NCICTEP_ClinRes @sarahe316422 @UPMCHillmanCC @MageeWomens @PittHealthSci 👏👏

[Alkis Papachristos, PharmD, PhD @alkis_p]

@ChristofidesCY @CCRI17 👏👏

[Petros Grivas @PGrivasMDPhD]

@HsiehLab @FaltasLab @FaltasLab is brilliant & very famous all over the world including Greek newspapers, proof here:
https://t.co/C5SEBr1nWv
@minaseconomides @DRBakaloudiMD @alkis_p @EfstathiouEleni @PavlosMsaouel @g_mountzios @MichalisLiontos @AKyriazoglou @mkmoutafi Bishoy will visit Greece soon!

[Alkis Papachristos, PharmD, PhD @alkis_p]

@EmilianoCocco2 @lcrf_org @metcrusaders @SylvesterCancer Congratulations!

[Alkis Papachristos, PharmD, PhD @alkis_p]

@RandySweisMD Congratulations!

[Alkis Papachristos, PharmD, PhD @alkis_p]

@panagis21 🤣🤣

[Alkis Papachristos, PharmD, PhD @alkis_p]

@joewilliams4689 @BOPACommittee Congrats @joewilliams4689! Well deserved

[Alkis Papachristos, PharmD, PhD @alkis_p]

I am glad to share our newest publication presenting a novel ML approach to identify predictive biomarkers in patients receiving Bevacizumab-based regimes for mCRC https://t.co/REar6E5mP2 #MachineLearning #colorectalcancer #PrecisionMedicine @EleniKaratz

[Alkis Papachristos, PharmD, PhD @alkis_p]

@PTarantinoMD 🤣

[Alkis Papachristos, PharmD, PhD @alkis_p]

@PGrivasMDPhD @CParkMD @ASCO @myESMO @BladderCancerUS @IBCG_BladderCA @IBCN1997 @eaonc Congratulations @PGrivasMDPhD Well deserved!!!

[Alkis Papachristos, PharmD, PhD @alkis_p]

@LeonidasPlatan1 👌🏻👌🏻

[The Pharmaceutical Journal @PJOnline_News]

DPYD genetic testing and the future of pharmacogenomic testing in routine care

#PJgenomics @JessicaKPharma1 @EmmaGrovesPharm @oncology_pharm @GeneticBill

https://t.co/Z9ppZ5E87F

[UChicago Medicine @UChicagoMed]

A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens. https://t.co/aWHpH5CW44

[Alkis Papachristos, PharmD, PhD @alkis_p]

@HowellJollyBody @AACR Congrats

[Alkis Papachristos, PharmD, PhD @alkis_p]

Last day of #ASCO2022 @ASCO it was great to be back in #Chicago, learn the latest advances in #oncology #immunoOncology and meeting many friends and colleagues. See you next year!

[Alkis Papachristos, PharmD, PhD @alkis_p]

Excited to attend Pharmacogenetic testing to personalize cancer therapy: ready or not? @ASCO #ASCO2022 moderated by Dr. O’Donnell